Credit Suisse Ag Clovis Oncology, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.05 - $1.3 $82 - $2,151	-1,655 Reduced 3.52%	45,297 $2,000
Q3 2022 Nov 10, 2022	SELL	$1.05 - $2.85 $8 - $22	-8 Reduced 0.02%	46,952 $56,000
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.96 $64,105 - $301,191	-101,754 Reduced 68.42%	46,960 $85,000
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $30,992 - $68,053	21,673 Added 17.06%	148,714 $301,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $19,467 - $34,319	7,210 Added 6.02%	127,041 $343,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $35,508 - $50,726	8,746 Added 7.87%	119,831 $536,000
Q2 2021 Aug 16, 2021	SELL	$5.02 - $7.05 $91,394 - $128,352	-18,206 Reduced 14.08%	111,085 $643,000
Q1 2021 May 14, 2021	SELL	$4.81 - $10.34 $1.4 Million - $3.01 Million	-290,897 Reduced 69.23%	129,291 $907,000
Q4 2020 Feb 12, 2021	SELL	$4.13 - $6.41 $128,492 - $199,427	-31,112 Reduced 6.89%	420,188 $2.02 Million
Q3 2020 Nov 13, 2020	SELL	$4.82 - $7.72 $318,235 - $509,705	-66,024 Reduced 12.76%	451,300 $2.63 Million
Q2 2020 Aug 12, 2020	BUY	$5.69 - $9.69 $2.09 Million - $3.56 Million	367,887 Added 246.18%	517,324 $3.49 Million
Q1 2020 May 13, 2020	SELL	$3.77 - $11.0 $107,893 - $314,809	-28,619 Reduced 16.07%	149,437 $951,000
Q4 2019 Feb 12, 2020	BUY	$3.0 - $16.43 $41,766 - $228,738	13,922 Added 8.48%	178,056 $1.86 Million
Q3 2019 Nov 12, 2019	SELL	$3.93 - $15.35 $318,098 - $1.24 Million	-80,941 Reduced 33.03%	164,134 $646,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $1.1 Million - $2.21 Million	85,981 Added 54.04%	245,075 $3.64 Million
Q1 2019 May 14, 2019	SELL	$17.66 - $30.28 $313,959 - $538,317	-17,778 Reduced 10.05%	159,094 $3.95 Million
Q4 2018 Feb 13, 2019	SELL	$11.63 - $32.67 $907,988 - $2.55 Million	-78,073 Reduced 30.62%	176,872 $3.18 Million
Q3 2018 Nov 13, 2018	BUY	$29.37 - $49.48 $2.94 Million - $4.94 Million	99,939 Added 64.47%	254,945 $7.49 Million
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $1.14 Million - $1.68 Million	-27,003 Reduced 14.84%	155,006 $7.05 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $4.44 Million - $6 Million	88,558 Added 94.76%	182,009 $9.61 Million
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $5.57 Million - $8.16 Million	-96,480 Reduced 50.8%	93,451 $6.36 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $1.97 Million - $2.48 Million	29,278 Added 18.22%	189,931 $15.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	160,653	160,653 $15 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account